Pharmaceutical companies are hurting millions of patients due to shortage of important drugs.
Despite the invitation to industry associations from the controlled division of DRAP to discuss the concerns of the industry on standard operating procedures for allocation of quota of controlled substance, they were not given a chance to discuss the issues they face in ensuring availability of medicines to the patients.
Shortage included the tablets and syrups for cold and cough,” said the source, adding that the shortage is creating room for counterfeit drugs along with smuggling of drugs.
The source added that the shortage is often created due to flaws in the release mechanism of controlled substance as the policy of allocating quota of controlled substances to pharmaceutical companies is causing delays in production of certain drugs.
Your email address will not be published. Required fields are marked *
17 November, 2019